TITLE

Use of orlistat to treat chylous ascites: a case report

AUTHOR(S)
Chen, Jaime; Hassanein, Tarek
PUB. DATE
September 2003
SOURCE
American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS208
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
An abstract of the article "Use of Orlistat to Treat Chylous Ascites: A Case Report" by Jaime Chen and Tarek Hassanein is presented.
ACCESSION #
66954881

 

Related Articles

  • Chylous ascites associated with gastroschisis. Solans, Cecilia Vaquero; Sockolow, Robbyn Ellen // Clinical Pediatrics;Aug1996, Vol. 35 Issue 8, p415 

    Focuses on a case of chylous ascites associated with gastroschisis. Background information; Symptoms; Diagnosis; Treatment.

  • Evaluation and Initial Management of Patients with Ascites. Lipsky, Martin S.; Sternbach, Marna R. // American Family Physician;9/15/1996, Vol. 54 Issue 4, p1327 

    Focuses on ascites. Definition; Pathophysiology; Detection; Evaluation; Management.

  • 'I would tell Mum firmly that I was certainly not going to prescribe any medication for her son'  // Pulse;10/14/2002, Vol. 62 Issue 39, p39 

    Presents the view of general practitioner on prescription of orlistat on diet. Disapproval on the use of orlistat; Issue on the safety and the efficacy of the drug; Importance of exercise and healthy diet.

  • Etoricoxib/furosemide/orlistat.  // Reactions Weekly;8/28/2010, Issue 1316, p22 

    The article describes the case of a 60-year-old woman who developed renal failure after taking orlistat and etoricoxib and furosemide abuse.

  • Orlistat/sitagliptin interaction.  // Reactions Weekly;5/15/2010, Issue 1301, p39 

    The article describes the case of a 53-year-old female patient who suffered from pancreatitis while taking sitagliptin for type 2 diabetes mellitus (T2DM), and orlistat for an unknown indication.

  • Response to Öncúl. Fukui, Michiaki; Kitagawa, Yoshihiro; Nakamura, Naoto; Yoshikawa, Toshikazu // Diabetes Care;Oct2002, Vol. 25 Issue 10, p1900 

    Comments on the study of the cost-effectiveness of orlistat among obese type 2 diabetic patients. Sufficiency of the estimation of the author on the impact of HbA[sub 1c] reduction; Relation between low density cholesterol level and coronary events; Reliability of the estimates.

  • Orlistat: should we worry about liver inflammation? Wilding, John // BMJ: British Medical Journal;5/4/2013, Vol. 346 Issue 7906, p8 

    The article presents the author's comments on the relationship between orlistat use and abnormalities of liver in Great Britain. It mentions that orlistat is an inhibitor related to intestinal and pancreatic lipases that was licensed for the treatment of overweight and obese people in 2008. It...

  • 3-Year-Old Boy with Severe Obesity and Pseudoacromegaly; Short course treatment with Orlistatâ„¢. Hasani-Ranjbar, Shirin; Shirzad, Nooshin; Bakhshi, Farhad Mashayekh // Iranian Journal of Diabetes & Lipid Disorders;2010, Vol. 9, p1 

    Specific syndromes and single-gene defects are rare causes of obesity, accounting for less than one percent of childhood obesity. Most endocrine and genetic causes of obesity are associated with short stature. The purpose of this paper was clinically and biochemically describe a toddler with...

  • METABOLIC DISORDERS.  // Nurse Practitioners Prescribing Reference;Summer2013, Vol. 20 Issue 2, p144 

    The article lists the precautions, interactions, and adverse reactions of the metabolic disorders drugs including Zovirax capsules, and Didrex for obesity, and Ansaid for arthritis/rheumatic disorders.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics